CANCER DRUG ABRAXANE® IN FOCUS AT INTERNATIONAL CONFERENCE Delegates to hear trial results for future possible ABRAXANE indications including lung cancer and melanoma Melbourne: 27 May 2010: World leading advanced breast cancer drug ABRAXANE® (nanoparticle albumin-bound paclitaxel) will be in focus at a leading international medical conference in Chicago next week. Specialised Therapeutics Australia Pty Ltd (STA), which
